Article
Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.
PloS one - 1 Jan 2013
Steele Anna M, Wensley Kirsty J, Ellard Sian, Murphy Rinki, Shepherd Maggie, Colclough Kevin, Hattersley Andrew T, Shields Beverley M
Abstract excerpt
AIMS: HaemoglobinA1c (HbA1c) is recommended for diabetes diagnosis but fasting plasma glucose (FPG) has been useful for identifying patients with glucokinase (GCK) mutations which cause lifelong persistent fasting hyperglycaemia. We aimed to derive age-related HbA1c reference ranges for these pat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
